A new study has successfully reversed both the biological and behavioral hallmarks of Alzheimer’s disease in mouse models. The research found that slowly depleting the presence of a certain enzyme can reverse the formation of amyloid plaques in the brain. Illustrating the tricky path current Alzheimer’s research faces, the study was published literally hours after giant pharmaceutical company Merck announced the cancellation of a Phase 3 clinical trial surrounding a drug that targets the exact same enzyme.
.. Continue Reading New study reverses Alzheimer’s in mice, while similar big clinical trial fails
- Scientists unclog genetic brain blockade in mice with Alzheimer’s
- Excess sugar linked to Alzheimer’s in new study
- Protein discovery sheds light on brain sediment behind Alzheimer’s disease
- Alzheimer’s blood test promises detection years before symptoms develop
- Diabetes drug found to reverse symptoms of memory loss in Alzheimer’s mice
- Alzheimer’s may be prevented by antibody-releasing implant